메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Hakmin Lee (Korea Brain Research Institute (KBRI) Daegu 41062 Republic of Korea) In Seon Jeon (Korea Brain Research Institute (KBRI) Daegu 41062 Republic of Korea) Hyun Jung Kim (Korea Brain Research Institute (KBRI) Daegu 41062 Republic of Korea)
저널정보
한국구조생물학회 Biodesign Biodesign 제8권 제1호
발행연도
2020.1
수록면
1 - 19 (19page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
The field of substrate transport systems has grown steadily over the past decade and is now considered important for developing treatments to diseases. Human solute carriers (SLCs) consist of more than 420 different transporters, organized into 65 families (http://slc.bioparadigms.org/) according to sequence homology and transport functions. SLCs mediate the movement of ions, drugs, and metabolites across cell membranes, and dysfunction is associated with various diseases such as diabetes, cancer, and central nervous system (CNS) disorders. Thus, SLCs are emerging as important targets for therapeutic intervention and drug discovery. Despite their importance, sequence and structural information on SLCs is lacking, but recent biochemical and computational advances have expanded our understanding of SLC pharmacology. In particular, structures of SLCs elucidated by X-ray crystallography and cryo-electron microscopy (EM) have facilitated structure-based ligand prediction, comparison and modeling of SLC transporters, and virtual screening of small molecule libraries. Most available SLC structures are from prokaryotes, all SLC structures are classified into four major groups based on protein fold, and major facilitator superfamily (MFS) and leucine transporters (LeuT) have received most attention. This review systematically analyses the structures of different SLCs, and their molecular mechanisms of action and substrate recognition. Understanding drug-transporter interactions at the molecular level is essential for designing drugs with optimal therapeutic effects. Finally, we summarize the latest research trends, applications and computational approaches to developing solutes selectivity and inhibitors, including modelling techniques focused on the structure-based drug design for human SLC transporters.

목차

등록된 정보가 없습니다.

참고문헌 (182)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0